Enabling anti-tumor immunity by unleashing ILC2

Cell Res. 2020 Jun;30(6):461-462. doi: 10.1038/s41422-020-0330-9.

Irene Mattiola^{1

2

3}, Andreas Diefenbach^{4

5

6}

¹ Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany.
² Berlin Institute of Health (BIH), Anna-Louisa-Karsch Strasse 2, 10117, Berlin, Germany.
³ Mucosal and Developmental Immunology, Deutsches Rheuma-Forschungszentrum, Charitéplatz 1, 10117, Berlin, Germany.
⁴ Laboratory of Innate Immunity, Department of Microbiology, Infectious Diseases and Immunology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany. andreas.diefenbach@charite.de.
⁵ Berlin Institute of Health (BIH), Anna-Louisa-Karsch Strasse 2, 10117, Berlin, Germany. andreas.diefenbach@charite.de.
⁶ Mucosal and Developmental Immunology, Deutsches Rheuma-Forschungszentrum, Charitéplatz 1, 10117, Berlin, Germany. andreas.diefenbach@charite.de.

No abstract available

Publication types